Trademark: 79311887
Word
TAUROKINASE
Status
Registered
Status Code
700
Status Date
Tuesday, July 5, 2022
Serial Number
79311887
Registration Number
6776841
Registration Date
Tuesday, July 5, 2022
Mark Type
4000
Filing Date
Friday, March 5, 2021
Published for Opposition
Tuesday, April 19, 2022

Trademark Owner History
TauroPharm GmbH - Original Registrant

Classifications
5 Medical preparations containing recombinant, fibrinolytically active urokinase or consisting thereof, in particular for use in combination with taurolidine-containing catheter lock solutions

Trademark Events
Oct 15, 2022
Final Disposition Notice Sent To Ib
Oct 15, 2022
Final Disposition Processed
Oct 5, 2022
Final Disposition Notice Created, To Be Sent To Ib
Jul 5, 2022
Notice Of Registration Confirmation Emailed
Jul 5, 2022
Registered-Principal Register
May 3, 2022
Notification Processed By Ib
Apr 19, 2022
Official Gazette Publication Confirmation E-Mailed
Apr 19, 2022
Published For Opposition
Apr 13, 2022
Notification Of Possible Opposition Sent To Ib
Apr 13, 2022
Notice Of Start Of Opposition Period Created, To Be Sent To Ib
Mar 30, 2022
Notification Of Notice Of Publication E-Mailed
Mar 16, 2022
Approved For Pub - Principal Register
Mar 15, 2022
Teas/Email Correspondence Entered
Mar 15, 2022
Correspondence Received In Law Office
Mar 14, 2022
Assigned To Lie
Mar 11, 2022
Teas Response To Office Action Received
Nov 15, 2021
Refusal Processed By Ib
Oct 25, 2021
Non-Final Action Mailed - Refusal Sent To Ib
Oct 25, 2021
Refusal Processed By Mpu
Oct 6, 2021
Non-Final Action (Ib Refusal) Prepared For Review
Oct 5, 2021
Non-Final Action Written
Sep 28, 2021
Assigned To Examiner
Jun 5, 2021
Application Filing Receipt Mailed
Jun 1, 2021
New Application Office Supplied Data Entered In Tram
May 27, 2021
Sn Assigned For Sect 66a Appl From Ib

Trademark Alertz updated from USPTO on 2030-01-24